sublayer sublayer sublayer sublayer sublayer
sublayer sublayer
We are the only society in the country duly-recognized as the specialty society for Plastic Surgery by both the Philippine Medical Association (PMA) and the Philippine College of Surgeons (PCS).

Board of Directors

President: Carlos I. Lasa, Jr., MD

Vice-President for External Affairs: Briccio G. Alcantara, MD
Vice-President for Internal Affairs: Jose Joven V. Cruz, MD

Secretary: Arnold S. Angeles, MD
Treasurer: Gerald C. Sy, MD
P.R.O.: Laurence T. Loh, MD

Directors
Angelito M. Alava
Catherine Y. Asedillo, MD
Jay G. Estoya, MD
Benjamin G. Herbosa, MD
Gene Gerald SJ Tiongco, MD

Immediate Past President
Alexander G. De Leon, MD

Read more...

Latest News

[News Life] PAPRAS warns public vs fake surgeons

News@6: PAPRAS, nagbabala vs. mga pekeng plastic surgeon

 

 

Meetings & Events

ISAPS Course Philippines

The ISAPS Course Philippines is hosted and coordinated by the Philippine Association of Plastic, Reconstructive & Aesthetic Surgeons, Inc. (PAPRAS) with ISAPS to feature the latest educational offerings from the ISAPS Instructional Courses. The three-day conference is filled with a comprehensive scientific program led by an international faculty and relevant social activities.

Read more...

Annual Beut & Jelks Symposium

The Annual Beut & Jelks Oculoplastic Symposium is an event of great interest of health care have to be held in October, between the 20th and the 23rd, in Mallorca. The symposium is a collaboration of two world-renowned surgeons, Dr. Francisco Javier Beut, based in Palma and Dr. Glenn Jelks professor at the New York University.

Read more...

 

Follow Us in Twitter!

PAPRAS on Stem Cell Therapy

  1. Stem cell therapy should be used in proven indications only (i.e. cancers of the blood and bone marrow, and some primary immune-deficiencies treated by autologous or allogenic stem cell transplants), and should be administered only by trained professionals in FDA accredited facilities.
  2. Unproven use of stem cell therapy in conditions such as heart, lung, neurologic, skin, rheumatologic, kidney and gastrointestinal diseases, diabetes mellitus, hypertension, autism, cancer, aging and aesthetics, HIV AIDS, etc., should be restricted to clinical trials only.
  3. When stem cell therapy is given under a clinical study, it is unethical to make patients pay for the treatment. The cost of treatment should be shouldered by the sponsor of the study.
  4. The Philippine FDA should strictly enforce its legal mandates and issue clearer regulations for stem cell therapy for practicing clinicians to safeguard the health of Filipinos.

PAPRAS on Practice of Cosmetic Surgery

The Philippine Association of Plastic, Reconstructive and Aesthetic Surgeons, Inc. (PAPRAS) holds the position taken by the Professional Regulatory Board of Medicine, (as articulated in its position paper on Stem Cell Medicine), that "at the present time, there is a universally accepted pathway to attaining the status of specialists, which is structured residency training with extensive supervised clinical experience, and with a system of quality assurance before a physician specialist is allowed to practice the specialty."

Cosmetic surgery is an integral part of the field of plastic surgery. The only accepted pathway to attaining the status of a specialist practicing cosmetic surgery in the Philippines is to undergo structured residency training in plastic and reconstructive surgery, which involves a minimum of three years in general surgery in an accredited general surgery training program recognized by the Philippine Society of General Surgery, and three years in plastic and reconstructive surgery, in an accredited training program recognized by PAPRAS and the Philippine Board of Plastic Surgery. Furthermore, PAPRAS is the only component society recognized by the P...

Read more...